Lv2
130 积分 2024-07-02 加入
Application of liquid chromatography–mass spectrometry to monitoring plasma cyclophosphamide levels in phase I trial cancer patients*
13天前
已完结
How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia
1个月前
已关闭
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
1个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1个月前
已完结
Bridging the Gap: Integrating External Beam Radiation Therapy Into the Management of Hepatocellular Carcinoma
1个月前
已关闭
OS benefit with first-line datopotamab deruxtecan in advanced-stage TNBC
2个月前
已完结
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
2个月前
已完结
A Novel Protocol for Global Standardization in Upper Extremity Indocyanine Green Lymphography
3个月前
已完结
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
3个月前
已完结
皖公网安备34019202002308
